Mr. Schallenberger will step into his role Jan. 16, according to a news release. He has more than 12 years of experience in the orthobiologics industry and previously worked at Surgenex.
“In this newly created role, Mark will drive the modernization of our production, lead the optimization of our processes and operations, and support the diversification and development of new product lines,” Sean Browne, president and CEO of Xtant Medical said in the release. “We look forward to Mark’s contributions to our key growth pillars.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
